Filter by:
Cardiovascular
May 2025
ASCPT Annual Meeting
Pharmacokinetics of EDG-7500, a First-in-Class Cardiac Sarcomere Modulator for the Treatment of Hypertrophic Cardiomyopathy
Cardiovascular
May 2025
Heart Failure & World Congress on Acute Heart Failure
CIRRUS-HCM: A Multiple-Dose Phase 2 Study of Safety, Tolerability, and Effects on Hemodynamics and Functional Capacity of the Novel Cardiac Sarcomere Modulator EDG-7500 in Hypertrophic Cardiomyopathy
Cardiovascular
December 2024
Global CVCT Forum
Hypertrophic Cardiomyopathies – New Challenges for Future Trials
Cardiovascular
December 2024
Global CVCT Forum
EDG-7500, a First-in-Class Cardiac Sarcomere Modulator, Demonstrates Favorable Tolerability, Safety, and Pharmacokinetics in Healthy Adults and Patients with Hypertrophic Cardiomyopathy
Cardiovascular
November 2024
American Heart Association Scientific Sessions 2024
Chronic administration of EDG-7500, a novel sarcomere modulator, prevents increases in cardiac mass, T1 relaxation time, and left ventricular end diastolic pressure in a Yucatan mini-pig model of genetic non-obstructive hypertrophic cardiomyopathy
Cardiovascular
September 2024
HFSA Annual Scientific Meeting 2024
